Mohamed Kharfan-Dabaja: Management of R/R mantle cell lymphoma by Amer Beitinjaneh at the IACH2024
Mohamed Kharfan-Dabaja shared a post on X:
“Outstanding presentation on management of relapsed/refractory mantle cell lymphoma by Amer Beitinjaneh at the IACH2024, COLYM in Paris.”
Amer Beitinjaneh shared this post, adding:
“Thank you, Mohamed Kharfan-Dabaja, Mohamad Mohty for the invitation to be on the faculty at the IACH meeting in Paris to share our update on the management of R/R mantle cell lymphoma.Truly impressed by the meeting agenda and organization. Looking forward to next year’s meeting.”
Sources: Mohamed Kharfan-Dabaja/X and Amer Beitinjaneh/X
Mohamed Kharfan-Dabaja, M.D., M.B.A. is the Vice Chair and a hematologist-oncologist in the Blood and Marrow Transplant and Cellular Therapy (CAR-T) programs at Mayo Clinic in Jacksonville, Florida. His primary research interest focuses on developing conditioning regimens for allogeneic stem cell transplants, particularly using reduced-intensity conditioning.
Amer Beitinjaneh is an Associate Professor of Medicine at the University of Miami Sylvester Comprehensive Cancer Center. He is a Clinical Investigator and leader of the Bone Marrow Transplantation and Cellular Therapy program. His clinical research focuses on the long-term effects of stem cell transplantation, alternative donor transplantation, targeted therapy, and immune and cellular therapies for aggressive lymphomas.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023